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BACKGROUND: Laparoscopic adrenalectomy (LA) for phaeochromocytoma is a feasible, safe and 
effective treatment. The effects of associated catecholamine release render LA more challenging, although
with comparable morbidity to LA for other diseases of the adrenal gland.
METHODS: Data from case records of 44 patients who underwent LAs between May 2002 and May 2006
were analysed retrospectively. The patients were divided into a phaeochromocytoma group (Group I) and
a non-phaeochromocytoma group (Group II). The aim of this study was to assess the operative course
and outcome of LA in the two groups.
RESULTS: The mean operating time and blood loss were slightly higher in LA for phaeochromocytomas
compared to LA for other pathologies, but these differences were not statistically significant. The mean
hospital stay was 3.84 days in both groups. The phaeochromocytoma group had a slightly higher compli-
cation rate of 21% compared to 12%. None of the procedures needed open conversion. A terminal hand
assist was employed in two patients in Group I and one patient in Group II. Two patients with bilateral
phaeochromocytoma had single stage bilateral LA.
CONCLUSION: LA is feasible and effective in phaeochromocytoma. It is associated with a slightly longer
operating time, more blood loss and complications when compared with non-phaeochromocytoma
masses. LA can be done in a single operation for bilateral masses. Terminal hand assist is a viable and
effective option for very large masses. [Asian J Surg 2007;30(4):244–9]
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Introduction
Since its first description in 1992, laparoscopic ad-
renalectomy (LA) has become the gold standard for 
adrenal surgery.1 LA in phaeochromocytoma has received 
considerable attention in view of the haemodynamic 
alterations resulting from the pneumoperitoneum and
manipulations during surgery. This was our endeavour 
to determine whether the outcome of LA was any dif-
ferent in phaeochromocytoma as compared to other
lesions.
Methods
Prospectively entered data of patients who underwent LA
between May 2002 and May 2006 were analysed. The
results of LA for phaeochromocytoma were then com-
pared with LA for adrenal lesions other than phaeochro-
mocytoma, assessing the operative course and outcome
of LA in the two groups. Group I (phaeochromocytoma
group) included 19 patients while group II (non-
phaeochromocytoma group) had 25 patients with adrenal
pathologies other than phaeochromocytoma.
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All patients underwent preoperative imaging by contrast-
enhanced computed tomography and biochemical eval-
uation, which included estimation of 24-hour urinary
vanillylmandelic acid (VMA), cortisol and metanephrines.
Metaiodobenzylguanidine scanning, iodonorcholesterol
scanning and magnetic resonance imaging were done in
selected patients. All masses found to be functional on
biochemical assay were adequately prepared preoperatively.
Phaeochromocytomas were prepared by adequate volume
replacement and control of hypertension with alpha block-
ade and beta blockade, if needed. Alpha-blockers were
started 1 week prior to surgery or if the patient developed
hypotension, at a dose of 1 mg of doxazosin and titrated
up to 2 mg. Patients with Conn’s syndrome received oral
potassium supplementation and spironolactone.
A single surgeon (HSB) performed the procedures using
the lateral transabdominal approach. Three ports were used
on the left side and four on the right with the patient in
the lateral decubitus kidney position. By an open Hasson’s
technique, a 10-mm camera port was inserted 2 cm above
the umbilicus at the lateral border of the rectus sheath.
Two working ports were used in the midclavicular line, a
10-mm port in the iliac region 5 cm medial to the anterior
superior iliac spine and a 5-mm port subcostally. An addi-
tional 5-mm epigastric port was used for liver retraction on
the right side. Carbon dioxide was used for insufflation
maintaining a pneumoperitoneal pressure of 12 mmHg.
On the left side, early control of the adrenal vein at its
origin from the renal vein was attained after colonic and
splenopancreatic mobilization. On the right side, the adre-
nal vein was exposed at the superomedial border of the
gland after mobilizing the right lobe of the liver and expos-
ing the subhepatic inferior vena cava. After control of the
adrenal vein with ligaclips, the gland was removed using
the Harmonic Scalpel™ (Johnson & Johnson Ethicon
Endo Surgery Inc., Cincinnati, OH, USA). Specimens were
retrieved after extending one of the port incisions. In two
cases with large masses, a midline epigastric incision was
used for terminal hand assist (technique described in
results section) and retrieval. The specimen was retrieved
through an existing tubectomy scar in a female who un-
derwent bilateral single stage adrenalectomy for multiple
endocrine neoplasia (MEN) 2A syndrome. In all the others,
the specimens were removed intact without morcellation
in an endo-catch bag.
The mean (95% confidence interval of mean lower and
upper bound) operating time, mean blood loss and hospital
stay in the two groups were assessed by statistical analysis
using SPSS version 11 (SPSS Inc., Chicago, IL, USA). The
statistical test used was the independent sample t test.
Intraoperative haemodynamic alteration was defined as 
a rise in systolic blood pressure by 30% and/or diastolic
pressure by 10% of baseline at any time from positioning,
induction, creating pneumoperitoneum and handling the
tumour. A fall in blood pressure by the same margins after
removal of the tumour was also considered as haemody-
namic alteration.
Results
Fifty-two LAs were done in 44 patients. These included 
30 females and 14 males with a mean age of 38.43 years
(range, 1–73 years). Final histopathology in 19 patients
showed phaeochromocytoma while 25 had other patholo-
gies. Eight patients underwent bilateral single stage LA
(phaeochromocytoma, n = 2; Cushing’s disease, n = 6). Sin-
gle stage bilateral LA for phaeochromocytoma was per-
formed in one female with MEN 2A syndrome and another
young boy with bilateral adrenal masses.
In the phaeochromocytoma group, mean age± standard
deviation was 33.79 ± 13.72 years. Ten of the masses were
on the right side, seven on the left side and two were bilat-
eral. The mean size (95% confidence interval of mean lower
and upper bound) of masses, operating time and blood
loss were 6 (5.11, 6.94) cm, 129.58 (100, 159) minutes and
79.74 (43, 116) mL, respectively (Tables 1 and 2).
In the non-phaeochromocytoma group, the mean age
of the patients was 41.9 ± 16.68 years. Of these, there were
nine on the left and 10 on the right side. Six patients with
Cushing’s disease underwent bilateral single stage LA.
The mean size of the masses was 5.06 (4.4, 5.7) cm. Mean
operating time was 103 (82.7, 124.4) minutes and mean
blood loss was 48 (25, 71) mL.
Using the independent sample t test, the differences
between various parameters in the two groups were not
found to be statistically significant.
The final histopathology of the masses is shown in the
Figure. A normal adrenal gland was removed in a teenage
boy with uncontrolled hypertension, which required
three drugs. His urinary VMA was elevated and a com-
puted tomography scan was misinterpreted to show a 
left adrenal mass. In retrospect, this occurred because a
prominent splenic notch was interpreted as an adrenal
adenoma.
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Of the 19 patients in the phaeochromocytoma group,
16 had hypertension preoperatively. Blood pressure resolved
with surgery alone in 12 patients (75%) and came under
control with a single drug in the remaining four patients.
In group II, 21 patients were hypertensive. Five patients
with Conn’s syndrome were cured after surgery.
Fifteen out of the 19 patients (78.9%) with phaeochro-
mocytoma had significant intraoperative alterations in
blood pressure. Three of these patients developed severe
hypertension during all stages of operation including
positioning, creation of pneumoperitoneum and tumour
dissection. Pneumoperitoneum per se did not result in sig-
nificant haemodynamic alterations in the other 11 patients.
The rise in blood pressure was adequately managed by
interruption of the procedure and sodium nitroprusside
infusion. Early venous control was aimed at in all patients.
All 15 patients had hypertension on handling the tumour.
Later, five of the patients developed hypotension for less
than 12 hours which required volume replacement in two
and a pressor agent (dopamine) in three. None of the
patients in the non-phaeochromocytoma group showed
any rise in blood pressure.
A complication rate of 21% (4/19) was seen in the
phaeochromocytoma group. Three patients developed pul-
monary oedema. Two of these resulted from intraoperative
haemodynamic alterations with fluid overload and required
postoperative ventilation for 8 hours. The third occurred
in a 72-year-old female with coronary artery disease, who
developed pulmonary oedema due to myocardial ischaemia
Table 1. Demographics of phaeochromocytoma (P) and non-phaeochromocytoma (Non P) masses
Study
Adrenal units (n) Approach Mean size (cm) Hospital stay (d)
P Non P P Non P P Non P P Non P
Kalady15 28 27/19* NA NA NA NA 3.4 –
Gotoh16 9 28 LTA LTA 5.4 2.4 NA NA
Kim et al17 26 34 NA NA 4.9 2.7 4 2
This study 21 31 LTA LTA 6 5 3.9 3.8
*Aldosteronoma/incidentaloma. NA = not applicable; LTA = lateral transperitoneal approach.
Table 2. Operative parameters of phaeochromocytoma (P) and non-phaeochromocytoma (Non P) masses
Study
Blood loss (mL) Complications (%) Conversion (%) Operating time (min)
P Non P P Non P P Non P P Non P
Kalady15 150 88/75* 10.8 – 10.8 – 171 171
Gotoh16 360 54 25 NA 11 NA 199 177
Kim et al17 276 196 23 8.8 3.8 2.9 191 162
This study 79.7 48 21 12 2 THA 1 THA 129.5 103
*Aldosteronoma/incidentaloma. NA = not applicable; THA = terminal hand assist.
Phaeochromocytoma Cortical hyperplasia Conn’s












Figure. Histopathology of the lesions: type and number in 52
adrenal units.
on the second postoperative day. She was managed con-
servatively. One patient with a large adherent phaeochro-
mocytoma required transfusion to replace intraoperative
blood loss.
The non-phaeochromocytoma group had a complica-
tion rate of 12% (3/25). This included one patient with
transient fever secondary to a subhepatic collection. This
patient had undergone concomitant de-roofing of a renal
cyst. One patient with a large tuberculous mass required a
blood transfusion and one patient with a large myelolipoma
developed infection of the incision. All these complications
resolved with conservative measures alone.
Terminal hand assist (THA), not amounting to open
conversion, was employed in two patients with large vas-
cular phaeochromocytomas in whom the procedure could
not be safely completed purely laparoscopically. In one
patient with a large left-side 11-cm mass, THA was done
through a midline supraumbilical incision. The second
indication was in a child with bilateral phaeochromo-
cytomas (5 cm on the left and 8 cm on the right). After
complete laparoscopic excision of the left-side mass, the
right-side tumour was extracted with a hand inserted
through a Pfannensteil incision towards the end of the
procedure. This was necessary because of the size, large
collateral vessels and retrocaval extension of the mass. In
group II, one patient with a large tuberculous gland that
was densely adherent (9 cm) required THA. No special
hand port device was needed for these procedures as they
were carried out for a very short period of time towards the
end of the operation. Loss of pneumoperitoneum could
be adequately reduced with manual compression around
the incision through which the hand was snugly inserted.
Discussion
LA has become the approach of choice for the management
of phaeochromocytoma.2 The incidence of haemodynamic
changes occurring during LA and open adrenalectomy
(OA) for phaeochromocytoma have been reported to be
similar.2 In fact, some studies have reported that the
episodes of haemodynamic instability with LA in phaeo-
chromocytomas have been observed to be equal to or lesser
than those observed during open surgery.3–6 This could
be because there is minimal handling of the tumour with
early control of the adrenal vein in LA in comparison to
OA. Although studies have shown that the late ligation of
the adrenal vein, as happens in the retroperitonoscopic
approach, does not affect the occurrence of hypertensive
episodes, it is felt that adequate preoperative alpha-receptor
blockade prevents these episodes.7–9 In our study, intra-
operative hypertensive events were seen in the majority of
patients (78.9%, 15/19) with phaeochromocytoma at vari-
ous times during surgery, in spite of adequate preoperative
preparation with alpha blockade and, when necessary,
beta blockade. In some cases, these episodes persisted even
after adequate control of the main adrenal vein, probably
due to catecholamine release through accessory adrenal
veins or collaterals. Although these haemodynamic alter-
ations were frequent, they could be controlled relatively
easily and quickly with drugs or temporary interruption
of the procedure. Postoperative hypotension seen in a few
patients could be managed with volume replacement and
pressor agents.
Many approaches to LA have been described. We prefer
the lateral transperitoneal approach (LTA) as the working
space is greater, exposure is good and larger masses can be
dealt with easily. Early control of the adrenal vein can also
be achieved with minimal manipulation of the tumour
with this approach. According to Janetschek et al, retro-
peritoneal endoscopic adrenalectomy (REA) did not offer
any clear advantage over LTA.3 Technically, it is often not
possible to approach the adrenal vein first by REA. For
obvious reasons, REA is preferable in patients who have
undergone previous laparotomy in the area of interest.
Whether CO2 insufflation and intra-abdominal pres-
sure may contribute to haemodynamic alteration during
LA for phaeochromocytomas has been an area of concern.
In general, prolonged laparoscopic surgery with CO2 may
induce cardiac arrhythmias due to acidosis-induced release
of catecholamines, especially in elderly patients. It is gener-
ally also observed that when effective ventilation techniques
and monitoring are applied, hypercarbia and hypoxia are
rarely encountered. Maintaining intra-abdominal pressure
less than 12 mmHg is recommended by most studies.10
The hypertensive response during the induction of pneu-
moperitoneum in phaeochromocytoma patients is not
significant and can be managed easily with antihyperten-
sive drugs. It is in fact the tumour manipulation that
causes the greatest rise in plasma catecholamine levels.11–13
Clinically significant haemodynamic alterations during
tumour manipulation were more commonly encountered
during conventional OA than during LA.13 It has been sug-
gested that a low intra-abdominal pressure of 8–10 mmHg
causes less catecholamine release and fewer haemodynamic
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fluctuations.14 Helium pneumoperitoneum has been tried
with good results, although randomized controlled trials
comparing helium and CO2 are not available.11,13 In our
study, CO2 was used and all procedures were completed
satisfactorily. We did not study catecholamine levels and
different pneumoperitoneal pressures.
The results of the present series in terms of operating
time, blood loss, conversion rates, complication rates and
hospital stay compare favourably with other large series15–17
(Table 2).
Gagner et al have reported greater complications in
phaeochromocytomas as compared to other lesions prob-
ably due to their larger sizes and haemodynamic alter-
ations. They concluded that LA is the procedure of choice
in phaeochromocytoma although it is associated with
more complications than LA for other lesions.18 The only
major complication faced in the present series was tran-
sient pulmonary oedema, probably due to the haemody-
namic alterations and fluid shifts associated with their
correction.
For large tumours, size makes dissection difficult and
time-consuming with a consequent increase in complica-
tions; in such cases, it may be prudent to employ hand
assistance.19 Due to cost constraints, we employed THA
laparoscopy (without any special hand port device) as an
effective variant of minimal access surgery. This approach
permitted successful completion of surgery for large and
adherent tumours (two phaeochromocytomas and one
tuberculous gland).
There are reports of recurrence following LA for large
phaeochromocytomas. These have occurred in malignant
lesions and when fragmentation of the tumour during
handling occurred.7,8 In the present series, we did not
experience rupture or recurrence in spite of four tumours
being larger than 8 cm. Longer follow-up may indicate the
true recurrence rates.
The 75% resolution rate of hypertension in our series
of phaeochromocytomas corresponds with that mentioned
in the literature (70–100%).3,6,7,11 The patients with per-
sistent hypertension were easily managed with one anti-
hypertensive medication. All patients with aldosteronomas
were successfully treated for hypokalaemia. One of the six
patients (16.7%) with Conn’s adenoma in our series had
persistent hypertension. A review of the literature indi-
cates a 12–34% persistence of hypertension (probably 
due to long-standing hypertension, age, family history of
hypertension and coexisting essential hypertension).20,21
LA has become the gold standard treatment for adre-
nal masses. LA can be safely and effectively performed in
phaeochromocytoma. The advantages of low morbidity,
fewer complications and quick recovery, along with cure
of hypertension and lack of hormonal recurrence, make
LA an attractive option in phaeochromocytoma. However,
it may be associated with slightly increased blood loss,
operating time and complication rates when compared to
LA for other adrenal pathologies. It can be performed
safely, bilaterally, and in a single stage in patients with
bilateral phaeochromocytoma when adequate expertise is
achieved. It is wise to consider a hand-assisted procedure
when the mass is large, adherent, hypervascular and has
retrocaval extension.
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